White Papers
-
Streamlining Clinical Trial Start-Up In Australia
10/20/2025
Gain a comprehensive overview of how sponsors can accelerate clinical trial start-up in Australia, leveraging the nation’s unique strengths as a global hub for clinical research.
-
The EMR Interoperability Dream Vs. Clinical Research Reality
10/20/2025
Seamless Electronic Medical Record access promises accelerated trials and regulatory-grade evidence, but incomplete, unstructured data requires hybrid strategies using AI and human oversight to bridge gaps.
-
Automated Evidence Generation For Regulatory-Grade RWD
10/20/2025
Global regulatory agencies increasingly adopt Real-World Evidence, demanding higher data quality and automated AI-driven platforms to meet evolving standards and improve drug development pathways.
-
The Case For A New Paradigm In Geographic Atrophy Clinical Trials
10/15/2025
Here, the author introduces a new framework for GA clinical development that integrates genetic profiling, novel biomarkers, and predictive analytics to improve precision, streamline design, and accelerate development.
-
Rethinking Clinical Operations: A Smarter, Faster Playbook For Trial Success
10/15/2025
The CRO-sponsor partnership is now strategic, addressing communication gaps and fragmented systems to improve efficiency. Joint governance, real-time tracking, and unified technology accelerate complex trial execution.
-
Conducting Early Phase Clinical Trials In Diverse Healthy Populations
10/14/2025
Download our guide to learn proven strategies for designing early phase clinical trials that successfully enroll diverse populations and meet FDA diversity guidance.
-
Global Vaccine Clinical Trials: Australia's Strategic Advantage
10/14/2025
The global vaccine clinical trials landscape presents unprecedented opportunities. This report analyses emerging trends, regional opportunities, and Australia’s distinctive strengths in vaccine development.
-
Eliminate Clinical Trial White Space With The Right AI Strategy
10/9/2025
Learn how sponsors and CROs are using agentic AI to eliminate the unproductive time caused by manual, sequential processes and fragmented data systems.
-
Gene Therapies For Rare Diseases: Platforms, Modalities, And Delivery Systems
10/6/2025
Examine the treatment landscape for rare diseases and the rapid evolution of gene therapy across three key dimensions: editing platforms, delivery modalities, and delivery vehicles.
-
Navigating Adverse Immunostimulation: A Practical Guide For Clinical Researchers
9/30/2025
Explore a systematic approach to evaluate adverse immunostimulation (AIS) in drug development through standardized biomarker sampling and tailored management strategies.